Lixte Biotechnology Holdings, Inc. (LIXT) analyst actions
Rating and price-target actions on LIXT in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the LIXT overview →
1 measured LIXT analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| IBN Initiates Coverage of LIXTE Biotechnology Holdings Inc. | Press release | +0.87% | -2.91% |
Keep exploring
More LIXT: earnings → · SEC filings → · LIXT overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Resverlogix Corp (RVX_TSE) | 240 | 0.00% | 32% |
| Artelo Biosciences, Inc. (ARTL) | 239 | 0.00% | 41% |
| MeiraGTx Holdings plc - Ordinary Shares (MGTX) | 239 | -0.10% | 46% |
| Ovid Therapeutics Inc. (OVID) | 239 | -0.32% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.